Leptospirose prevention Position IMAXIO as a partner for public health and occupational safety by offering targeted leptospirosis awareness, prevention education, and vaccination research support to healthcare authorities, employers with high exposure risk, and professional associations.

Small biotech traction Leverage the compact team size and entrepreneurial agility to offer bespoke consulting, rapid pilots, and co-development opportunities with larger pharma players seeking niche leptospirosis or zoonosis expertise.

Public health partnerships Highlight collaboration potential with health authorities and professional sites such as leptospirose-prevention.fr to co-create educational campaigns, surveillance tools, and preventative programs that open doors for funded initiatives.

Funding and growth With a modest revenue base and recent funding, pursue grant-supported R&D partnerships, contract research services, and milestone-driven collaborations to scale capabilities and validate offerings.

Digital readiness Utilize existing tech stack and digital platforms to offer scalable outreach, socialization of study findings, and targeted marketing to laboratories, hospitals, and occupational health services seeking leptospirosis insights.